Abstract
To examine the clinical attributes and likelihood of lymph node metastasis (LNM) in patients with differentiated thyroid carcinoma classified as clinically lymph node-negative (cN0), with a minimum tumor diameter > 0.5 cm and maximum tumor diameter < 3.0 cm. Clinical data of 232 patients who underwent radical thyroidectomy and satisfied the inclusion and exclusion criteria were collected, and we found that average age of the LNM-positive group was younger than that of the LNM-negative group (40.9 ± 10.8 vs. 45.3 ± 11.8, P = 0.0031); sex distribution also showed a statistically significant difference, with male patients being more prone to LNM (P = 0.0436). Patients with positive LNM exhibited higher ultrasound thyroid imaging reporting and data system (TI-RADS) scores for thyroid nodules (p < 0.001). In terms of maximum tumor diameter and RET fusion, the LNM-positive group was higher in LNM-negative group (1.11 ± 0.832 cm vs. 0.808 ± 0.616 cm, P = 0.0034 and 16.3% vs. 2.7%, P = 0.0026), showing a statistically significant difference, The proportion of multifocal lesions was also higher in the LNM-positive group (26.8% vs. 20.2%). Patients in the LNM-positive group had higher levels of peripheral blood thyroid stimulating hormone (2.68 ± 2.88 μIU/L vs. 2.12 ± 2.07 μIU/L). Notably, statistically significant differences were observed between the LNM-positive and negative groups in terms of prothrombin time activity (PT%) (110 ± 13.0% vs. 107 ± 11.5%, P = 0.034) and white blood cell (WBC) count (6.11 ± 1.76 × 10^9/L vs. 6.59 ± 1.85 × 10^9/L, P = 0.0495), and further investigations revealed that BMI (R = 0.19) and blood urea nitrogen (R = 0.17) were positively correlated with PT%, whereas PT% was negatively correlated with peripheral blood T3 (R = − 0.17) and T4 (R = − 0.13) levels, which has not been reported in previous studies. We observed that for patients with cN0 differentiated thyroid cancer, we should also pay attention to the influence of factors such as gender, age, tumor diameter, RET fusion, and even PT and WBC on lymph node metastasis.
Data availability
The datasets analyzed in the current study are available from the corresponding author on reasonable request.
References
Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl. Cancer Cent. 4(1), 47–53 (2024).
Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3), 229–263 (2024).
Cabanillas, M. E., McFadden, D. G. & Durante, C. Thyroid cancer. Lancet 388(10061), 2783–2795 (2016).
Prabhu, M., Shakya, S., Ballal, S., Ahmed Shamim, S. & Bal, C. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients. Nucl. Med. Commun. 41(11), 1136–1142 (2020).
Zhou, S. L. et al. Predicting factors of central lymph node metastasis and BRAF(V600E) mutation in Chinese population with papillary thyroid carcinoma. World J. Surg. Oncol. 19(1), 211 (2021).
Nie, X., Tan, Z. & Ge, M. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice. BMC Cancer 17(1), 702 (2017).
Caliskan, O. et al. Predictive factors affecting the development of lateral lymph node metastasis in papillary thyroid cancer. Sisli Etfal Hastan 57(3), 312–319 (2023).
Yu, J. et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat Commun. 11(1), 4807 (2020).
Yu, Y. et al. Artificial intelligence-based multi-modal multi-tasks analysis reveals tumor molecular heterogeneity, predicts preoperative lymph node metastasis and prognosis in papillary thyroid carcinoma: a retrospective study. Int. J. Surg. 111(1), 839–856 (2025).
Liu, F. et al. Meta-analysis of prediction models for predicting lymph node metastasis in thyroid cancer. World J. Surg. Oncol. 22(1), 278 (2024).
Du, Y. et al. Mutational profiling of Chinese patients with thyroid cancer. Front. Endocrinol. (Lausanne). 14, 1156999 (2023).
Wang, C. et al. Geographic disparities in trends of thyroid cancer incidence and mortality from 1990 to 2019 and a projection to 2030 across income-classified countries and territories. J. Glob. Health. 13, 04108 (2023).
Oh, M. Y. et al. Distinct impacts of clinicopathological and mutational profiles on long-term survival and recurrence in medullary thyroid carcinoma. Endocrinol. Metab. 39(6), 877–890 (2024).
Fu, R. et al. PTC-MAS: A deep learning-based preoperative automatic assessment of lymph node metastasis in primary thyroid cancer. Diagnostics 13(10), 1723 (2023).
Zhu, H. et al. Models of ultrasonic radiomics and clinical characters for lymph node metastasis assessment in thyroid cancer: A retrospective study. PeerJ 11, e14546 (2023).
Rezaei, F. et al. Temporal trends of thyroid cancer between 2010 and 2019 in Asian countries by geographical region and SDI, comparison with global data. Aging Med. 6(4), 386–426 (2023).
Zhang, M. B. et al. Cervical lymph node metastasis prediction from papillary thyroid carcinoma US videos: A prospective multicenter study. BMC Med. 22(1), 153 (2024).
Wang, J. et al. Young age increases the risk of lymph node positivity in papillary thyroid cancer patients: A SEER data-based study. Cancer Manag. Res. 10, 3867–3873 (2018).
Xu, F. Z. et al. Serum sex hormones correlate with pathological features of papillary thyroid cancer. Endocrine 84(1), 148–154 (2024).
Lu, X. et al. Combining thyroglobulin levels in lymph node wash-out fluid with TI-RADS to predict lymph node metastasis in papillary thyroid carcinoma. Malawi Med. J. 36(5), 298–302 (2025).
Zhong, M. et al. The predictive value of ACR TI-RADS classification for central lymph node metastasis of papillary thyroid carcinoma: A retrospective study. Int. J. Endocrinol. 2022, 4412725 (2022).
Zhang, Y. et al. Contrast-enhanced ultrasonography with intra-glandular contrast injection can improve the diagnostic accuracy of central compartment lymph node metastasis of thyroid cancer. Nan Fang Yi Ke Da Xue Xue Bao 43(2), 219–224 (2023).
Chen, L., Liu, Z. Y. & Zhang, J. S. Clinical and cytological characteristics of primary thyroid lymphoma: A fine needle aspiration study of 10 cases. Zhonghua Bing Li Xue Za Zhi 54(6), 618–625 (2025).
Carvalho, A. Y., Kohler, H. F., Gomes, C. C., Vartanian, J. G. & Kowalski, L. P. Predictive factors of recurrence of papillary thyroid microcarcinomas: Analysis of 2,538 patients. Int. Arch. Otorhinolaryngol. 25(4), e585–e593 (2021).
Yang, L. G., Yang, Z. G., Zhang, J. & Fu, Y. L. Effects of (131)I and TSH suppression therapy on METTL3, METTL14 levels and recurrence in thyroid cancer. Am. J. Cancer Res. 15(1), 42–58 (2025).
Li, Z. et al. Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients. Front. Immunol. 14, 1273422 (2023).
Gan, D. et al. Development of a novel prognostic assessment model for hepatitis B virus-related acute-on-chronic liver failure based on reexamination results. Medicine 102(11), e33252 (2023).
Bian, Z. et al. Prognostic role of prothrombin time activity, prothrombin time, albumin/globulin ratio, platelets, sex, and fibrinogen in predicting recurrence-free survival time of renal cancer. Cancer Manag. Res. 12, 8481–8490 (2020).
Wang, X., Wang, J. Y., Chen, M., Ren, J. & Zhang, X. Clinical association between coagulation indicators and bone metastasis in patients with gastric cancer. World J. Gastrointest. Oncol. 15(7), 1253–1261 (2023).
Li, Y., Xu, C. & Yu, Q. Risk factor analysis of bone metastasis in patients with non-small cell lung cancer. Am. J. Transl. Res. 14(9), 6696–6702 (2022).
Zhang, L. et al. Prediction of poor outcomes in patients with colorectal cancer: Elevated preoperative prothrombin time (PT) and activated partial thromboplastin time (APTT). Cancer Manag. Res. 12, 5373–5384 (2020).
Weitz, J. I., Fredenburgh, J. C. & Eikelboom, J. W. A test in context: D-dimer. J. Am. Coll. Cardiol. 70(19), 2411–2420 (2017).
Johnson, E. D., Schell, J. C. & Rodgers, G. M. The D-dimer assay. Am. J. Hematol. 94(7), 833–839 (2019).
Pasqual, E., O’Brien, K., Rinaldi, S., Sandler, D. P. & Kitahara, C. M. Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: Results from a prospective cohort study (Sister Study). Lancet Reg. Health Am. 23, 100537 (2023).
Mukherjee, S. et al. IL-17 a correlates with disease progression in papillary thyroid carcinoma. Diagn Pathol. 18(1), 93. https://doi.org/10.1186/s13000-023-01362-4 (2023).
Kim, E. H. et al. Association of the preoperative neutrophil-to-ymphocyte count ratio and platelet-to-lymphocyte count ratio with clinicopathological characteristics in patients with papillary thyroid cancer. Endocrinol. Metab. 30(4), 494–501. https://doi.org/10.3803/EnM.2015.30.4.494 (2015).
Funding
This study was supported by the Anhui Provincial Special Program for Clinical Medical Research Translation.202527c10020076.
Author information
Authors and Affiliations
Contributions
M.W.: Conceptualization (equal); investigation (equal); visualization (equal); writing—original draft (equal). K.H.: Data curation (equal); formal analysis (equal). G.Q.: Resources (equal); software (equal); visualization (equal). Q.L.: Investigation (equal); validation (equal); visualization (equal). J.Q.: Resources (equal); supervision (equal); validation (equal). Y.L.: Investigation (equal); supervision (equal); writing—review and editing (equal). R.W.: Conceptualization (equal); data curation (equal); writing—review and editing (equal).
Corresponding authors
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wei, M., Hu, K., Qiu, G. et al. Clinical characteristics and risk analysis of lymph node metastasis in patients with cN0 differentiated thyroid carcinoma. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39630-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-39630-0
